Erica O’Bryan

1.2k total citations
8 papers, 930 citations indexed

About

Erica O’Bryan is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Erica O’Bryan has authored 8 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Hematology. Recurrent topics in Erica O’Bryan's work include Cell death mechanisms and regulation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Erica O’Bryan is often cited by papers focused on Cell death mechanisms and regulation (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Chronic Myeloid Leukemia Treatments (3 papers). Erica O’Bryan collaborates with scholars based in United States and Canada. Erica O’Bryan's co-authors include Ramadevi Nimmanapalli, Kapil N. Bhalla, Olivier Déry, Kathryn DeFea, Nigel W. Bunnett, Purva Bali, Hong‐Gang Wang, Fei Guo, David Griffin and Shanthi R. Paranawithana and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Clinical Cancer Research.

In The Last Decade

Erica O’Bryan

7 papers receiving 912 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erica O’Bryan United States 7 709 210 192 132 115 8 930
Art Raitano United States 4 678 1.0× 84 0.4× 224 1.2× 192 1.5× 126 1.1× 4 1.0k
Ron de Jong United States 19 1.1k 1.5× 73 0.3× 224 1.2× 289 2.2× 164 1.4× 33 1.6k
Gautam Sondarva United States 18 840 1.2× 78 0.4× 118 0.6× 240 1.8× 58 0.5× 28 1.1k
Dwight M. Morrow United States 14 950 1.3× 92 0.4× 101 0.5× 213 1.6× 36 0.3× 33 1.3k
Patricia A. Zipfel United States 16 596 0.8× 72 0.3× 116 0.6× 283 2.1× 79 0.7× 21 1.0k
Christian Beerli Switzerland 18 854 1.2× 42 0.2× 75 0.4× 170 1.3× 81 0.7× 31 1.2k
Alison O’Mahony United States 11 665 0.9× 50 0.2× 256 1.3× 247 1.9× 193 1.7× 19 1.2k
Elzbieta Radziejewska United States 8 427 0.6× 51 0.2× 222 1.2× 150 1.1× 280 2.4× 8 851
Fabienne Maurer Switzerland 15 598 0.8× 91 0.4× 90 0.5× 151 1.1× 24 0.2× 24 916
Nathan West United States 10 1.2k 1.7× 43 0.2× 209 1.1× 398 3.0× 180 1.6× 10 1.5k

Countries citing papers authored by Erica O’Bryan

Since Specialization
Citations

This map shows the geographic impact of Erica O’Bryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erica O’Bryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erica O’Bryan more than expected).

Fields of papers citing papers by Erica O’Bryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erica O’Bryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erica O’Bryan. The network helps show where Erica O’Bryan may publish in the future.

Co-authorship network of co-authors of Erica O’Bryan

This figure shows the co-authorship network connecting the top 25 collaborators of Erica O’Bryan. A scholar is included among the top collaborators of Erica O’Bryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erica O’Bryan. Erica O’Bryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
2.
Gasparetto, Maura, Tracy Gentry, Saı̈d M. Sebti, et al.. (2004). Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening. Journal of Immunological Methods. 292(1-2). 59–71. 33 indexed citations
3.
Nimmanapalli, Ramadevi, Erica O’Bryan, Deborah J. Kuhn, et al.. (2003). Regulation of 17-AAG—induced apoptosis: role of Bcl-2, Bcl-xL, and Bax downstream of 17-AAG—mediated down-regulation of Akt, Raf-1, and Src kinases. Blood. 102(1). 269–275. 80 indexed citations
4.
Nimmanapalli, Ramadevi, Purva Bali, Erica O’Bryan, et al.. (2003). Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells.. PubMed. 63(22). 7950–8. 43 indexed citations
5.
6.
Nimmanapalli, Ramadevi, Erica O’Bryan, Mei Huang, et al.. (2002). Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.. PubMed. 62(20). 5761–9. 91 indexed citations
7.
Nimmanapalli, Ramadevi, Erica O’Bryan, & Kapil N. Bhalla. (2001). Geldanamycin and its analogue 17-allylamino-17-demethoxygeldanamycin lowers Bcr-Abl levels and induces apoptosis and differentiation of Bcr-Abl-positive human leukemic blasts.. PubMed. 61(5). 1799–804. 215 indexed citations
8.
DeFea, Kathryn, et al.. (2000). The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex. Proceedings of the National Academy of Sciences. 97(20). 11086–11091. 332 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Art Raitano Breakdown of academic impact, for papers by Ron de Jong Breakdown of academic impact, for papers by Gautam Sondarva Breakdown of academic impact, for papers by Dwight M. Morrow Breakdown of academic impact, for papers by Patricia A. Zipfel Breakdown of academic impact, for papers by Christian Beerli Breakdown of academic impact, for papers by Alison O’Mahony Breakdown of academic impact, for papers by Elzbieta Radziejewska Breakdown of academic impact, for papers by Fabienne Maurer Breakdown of academic impact, for papers by Nathan West
Rankless by CCL
2026